Evaluation of Rheumatoid Factor, Anti - Cyclic citrullinated peptide, Erythrocyte Sedimentation Rate, and Cell Reactive Protein in diagnosis of Rheumatoid
Abstract
Rheumatoid arthritis (RA) is an autoimmune disease that causes synovial inflammation, which leads to joint erosion. A group of factors contribute to the occurrence of the disease, including ecological and hereditary features, which can lead to the disease's progress. This study investigated the association between rheumatoid disease and various biomarkers, including RF, anti-CCP, ESR, and CRP. The study aimed to determine the ability of these biomarkers to diagnose rheumatoid disease. Materials and Methods: 100 samples were collected from patients suspected of having rheumatoid arthritis from Al-Sadr Medical City in Najaf/Iraq, the samples were diagnosed by the consultant and the arthritis unit in the abovementioned hospitals from August 2023 to February 2024. Then 50 samples were collected from healthy people as a control group. five ml of intravenous blood was drawn from both patients and controls, and the sera were separated by centrifugation, kept at −20°C, and tested. RF was detected by agglutination of RF latex strips (Solarbio/China), ESR, and CRP. Antibodies to CCP were measured by (ELISA) kit from Genius/USA protocol. Results: The results showed that rheumatoid arthritis was significantly associated with age and gender. patients 24(24%) had a family history of genetic factors. while 76 (76%) were affected by other non-genetic factors. In this study, there is a highly significant difference (P<0.01) And the chi-square was 75. When comparing the RF group with the control group, the RF gave a positive result (84%), while 16 (16%) gave a negative result for the RF, compared with the control. The negative results for the RF were 45 (90%) and 5 (10%) gave positive results. a significant difference (P<0.01) and a chi-square of 122 when comparing between the anti-CCP group and the control group. Anti-CCP gave 93 (93%) positive results for RA compared to the control, 50 (100%) gave negative results (RF, Anti-ccp), (ESR, CRP) also significantly increased in RA. the sensitivity results showed that 84% of tested cases indicated positive results for RF. RF is found in cases of rheumatoid arthritis with a sensitivity of 84%. On the other hand, the specificity result indicates that 90% of healthy controls tested negative for RF. Therefore, RF may be a good indicator for monitoring RA, where positive findings are more prevalent. The susceptibility result indicates that all cases tested showed positive results for ANTI-CCP. ANTI-CCP is present in RA cases with a sensitivity of 93%. It is noteworthy that the specificity is also 100%, indicating that no positive results for ANTI-CCP were found in the healthy control group tested. Therefore, ANTI-CCP is a highly sensitive and specific indicator of RA. Conclusion: The research exposed a notable association between rheumatoid disease and age as well as gender. The occurrence of Anti-CCP demonstrated higher diagnostic accuracy for rheumatoid disease compared to RF alone, as indicated by their sensitivity and specificity. Moreover, ESR and CRP levels were meaningfully raised in individuals with rheumatoid disease, further supporting their role as dependable markers for measuring disease activity. These findings significantly contribute to our understanding of the analytic and prognostic value of these biomarkers in rheumatoid disease.
References
2. Alpízar-Rodríguez, D., Pluchino, N., Canny, G., Gabay, C., & Finckh, A. (2017). The role of female hormonal factors in the development of rheumatoid arthritis. Rheumatology, 56(8), 1254-1263.
3. Babaahmadi, M., Tayebi, B., Gholipour, N. M., Kamardi, M. T., Heidari, S., Baharvand, H., ... & Hassani, S. N. (2023). Rheumatoid arthritis: the old issue, the new therapeutic approach. Stem Cell Research & Therapy, 14(1), 268.
4. Mahmoudi, M., Kheder, R. K., Faraj, T. A., Abdulabbas, H. S., & Esmaeili, S. A. (2023). Impacts of Porphyromonas gingivalis periodontitis on rheumatoid arthritis autoimmunity. International Immunopharmacology, 118, 109936.
5. Banerjee, S., & Falls, S. (2021, september). gender modifies the effect of rheumatoid arthritis on all-cause mortality. in arthritis & rheumatology (vol. 73, pp. 1200-1202). 111 river st, hoboken 07030-5774, nj usa: wiley.
6. Bitik, B., Mercan, R., Tufan, A., Tezcan, E., Küçük, H., İlhan, M., ... & Göker, B. (2015). Differential diagnosis of elevated erythrocyte sedimentation rate and C-reactive protein levels: a rheumatology perspective. European Journal of Rheumatology, 2(4), 131.
7. Buckman, T. A., Sakyi, S. A., Yeboah-Mensah, K., Antwi, M. H., Darban, I., Owusu-Brenya, L., ... & Tandoh, S. (2024). Demographic, Clinical Profile of Rheumatoid Arthritis Patients and Their Association with Disease Severity in Ghana. International Journal of Rheumatology, 2024.
8. Di Matteo, A., Bathon, J. M., Emery, P. (2023). Rheumatoid arthritis. The Lancet, 402(10416), 2019-2033. ISSN 0140-6736.
9. Frisell, T., Saevarsdottir, S. & Askling, J. Family history of rheumatoid arthritis: an old concept with new developments. Nat Rev Rheumatol 12, 335–343 (2016).
10. Gravallese, E. M., & Firestein, G. S. (2023). Rheumatoid arthritis—common origins, divergent mechanisms. New England Journal of Medicine, 388(6), 529-542.
11. Hashiam, M. D., & Aldahhan, H. A. A. (2022). Assessment of Auto-antibodies (RF, Anti-CCP, and Anti-RA33) in Rheumatoid Arthritis Patients: Comparative study. International Journal of Health Sciences, 6(S5), 5434–5444.
12. Ingegnoli F, Castelli R, Gualtierotti R. Rheumatoid factors: clinical applications. Dis Markers. 2013;35(6):727–34.
13. Jasim, R. A., Alchalabi, R., & Jaafer, R. S. (2024). The association between body mass index, diagnostic markers, and disease activity score with progression of rheumatoid arthritis in a sample of Iraqi patients. Journal of Biotechnology Research Center, 18(1), 5-10.
14. Kamil, S. A., & Aldahhan, H. A. A. (2022). Analysis of Proteus mirabilis proteins by using SDS-page technique in rheumatoid arthritis patients: Comparative study. International Journal of Health Sciences, 6(S4), 3544–3552
15. Kay, J., Morgacheva, O., Messing, S. P., Kremer, J. M., Greenberg, J. D., Reed, G. W., ... & Furst, D. E. (2014). Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcomes at one year. Arthritis research & therapy, 16, 1-10.
16. Kronzer, V. L., Crowson, C. S., Sparks, J. A., Myasoedova, E., & Davis III, J. (2021). Family history of rheumatic, autoimmune, and nonautoimmune diseases and risk of rheumatoid arthritis. Arthritis care & research, 73(2), 180-187.
17. Mun, S., Lee, J., Park, M., Shin, J., Lim, M. K., & Kang, H. G. (2021). Serum biomarker panel for the diagnosis of rheumatoid arthritis. Arthritis Research & Therapy, 23, 1-
18. Murata, K., Hashimoto, M., Yamamoto, W., Son, Y., Amuro, H., Nagai, K., ... & Matsuda, S. (2020). The family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patients is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWER cohort study. Rheumatology International, 40(2), 217-225.
19. Murata, K., Hashimoto, M., Yamamoto, W., Son, Y., Amuro, H., Nagai, K., ... & Matsuda, S. (2020). The family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patients is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWER cohort study. Rheumatology International, 40(2), 217-225.
20. Pope, J. E., & Choy, E. H. (2021, February). C-reactive protein and implications in rheumatoid arthritis and associated comorbidities. In Seminars in arthritis and rheumatism (Vol. 51, No. 1, pp. 219-229). WB Saunders
21. Raine, C., & Giles, I. (2022). What is the impact of sex hormones on the pathogenesis of rheumatoid arthritis? Frontiers in Medicine, 9, 909879.
22. Romão, V. C., & Fonseca, J. E. (2021). Etiology and risk factors for rheumatoid arthritis: a state-of-the-art review. Frontiers in medicine, 8, 689698.
23. Samanci, N., Ozdem, S., Akbas, H., Mutlu, D., Gultekin, M., Arman, M., & Donmez, L. (2005). Diagnostic value and clinical significance of anti-CCP in patients with advanced rheumatoid arthritis. Journal of the National Medical Association, 97(8), 1120.
24. Shi, G., Liao, X., Lin, Z., Liu, W., Luo, X., Zhan, H., & Cai, X. (2023). Estimation of the global prevalence, incidence, years lived with disability of rheumatoid arthritis in 2019 and forecasted incidence in 2040: results from the Global Burden of Disease Study 2019. Clinical Rheumatology, 42(9), 2297-2309.
25. Wen, Y. P., & Yu, Z. G. (2023). Identifying shared genetic loci and common risk genes of rheumatoid arthritis associated with three autoimmune diseases based on large-scale cross-trait genome-wide association studies. Frontiers in Immunology, 14, 1160397

This work is licensed under a Creative Commons Attribution 4.0 International License.